Journal article · 2014 · Open access

Self-reported efficacy of neurofeedback treatment in a clinical randomized controlled study of ADHD children and adolescents

Nezla S. Duric, Irene Bircow Elgen, Jörg Aßmus

Neuropsychiatric Disease and Treatment, 10, 1645 · Published 1 September 2014 · DOI 10.2147/ndt.s66466

Open PDFView at the publisherCite this paper

In brief

“Self-reported efficacy of neurofeedback treatment in a clinical randomized controlled study of ADHD children and adolescents” is a 2014 journal article by Nezla S. Duric and 2 co-authors, published in Neuropsychiatric Disease and Treatment. OpenAlex counts 38 citations as of 20 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at Neuropsychiatric Disease and Treatment.

Citations
38
Most cited in
2017 (6)
Field-weighted impact
1.86
References
64
Authors
3

Abstract

BACKGROUND: Many non-pharmacological treatments for children and adolescents with attention-deficit/hyperactivity disorder (ADHD) have been attempted, but reports indicate that most are ineffective. Although neurofeedback (NF) is a treatment approach for children with ADHD that remains promising, a variety of appropriate measures have been used in reporting and evaluating its effect. OBJECTIVE: To report the self-evaluations of NF treatment by children and adolescents with ADHD. METHODS: Randomized controlled trial in 91 children and adolescents with ADHD, aged less than 18 years (mean, 11.2 years) participated in a 30-session program of intensive NF treatment. Participants were randomized and allocated by sequentially numbered sealed envelopes into three groups: methylphenidate (MPH) as an active control group, and two trial groups NF with MPH, and NF alone. ADHD core symptoms and school performance were given on a scale of 1 to 10 using a self-reporting questionnaire, and the changes in these scores after treatment were used as the self-reported evaluation. Basic statistical methods (descriptive, analyses of variance, exact χ (2) test, and paired t-test) were used to investigate the baseline data. Changes in ADHD core symptoms and treatment effects were investigated using a general linear model for repeated measures. RESULTS: Eighty participants completed the treatment study and 73 (91%) responded sufficiently on the self-reporting questionnaires. The treatment groups were comparable in age, sex, and cognition as well as in the baseline levels of core ADHD symptoms. All treatments resulted in significant improvements regarding attention and hyperactivity (P<0.001), and did not differ from each other in effectiveness. However, a significant treatment effect in school performance was observed (P=0.042), in which only the NF group showed a significant improvement. CONCLUSION: The self-reported improvements in ADHD core symptoms and school performance shortly after treatment indicate NF treatment being promising in comparison with medication, suggesting NF as an alternative treatment for children and adolescents who do not respond to MPH, or who suffer side effects. Further long-term follow-up is needed.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Duric, N. S., Elgen, I. B., & Aßmus, J. (2014). Self-reported efficacy of neurofeedback treatment in a clinical randomized controlled study of ADHD children and adolescents. Neuropsychiatric Disease and Treatment, 10, 1645. https://doi.org/10.2147/ndt.s66466

MLA 9

Duric, Nezla S., et al. “Self-reported efficacy of neurofeedback treatment in a clinical randomized controlled study of ADHD children and adolescents.” Neuropsychiatric Disease and Treatment, vol. 10, 2014, p. 1645. https://doi.org/10.2147/ndt.s66466.

Chicago

Duric, Nezla S., Irene Bircow Elgen, and Jörg Aßmus. 2014. “Self-reported efficacy of neurofeedback treatment in a clinical randomized controlled study of ADHD children and adolescents.” Neuropsychiatric Disease and Treatment 10: 1645. https://doi.org/10.2147/ndt.s66466.

Harvard

Duric, N. S., Elgen, I. B. and Aßmus, J. (2014) ‘Self-reported efficacy of neurofeedback treatment in a clinical randomized controlled study of ADHD children and adolescents’, Neuropsychiatric Disease and Treatment, 10, p. 1645. doi:10.2147/ndt.s66466.

IEEE

N. S. Duric, I. B. Elgen, and J. Aßmus, “Self-reported efficacy of neurofeedback treatment in a clinical randomized controlled study of ADHD children and adolescents,” Neuropsychiatric Disease and Treatment, vol. 10, p. 1645, 2014, doi: 10.2147/ndt.s66466.

BibTeX

@article{duric2014self,
  title     = {{Self-reported efficacy of neurofeedback treatment in a clinical randomized controlled study of ADHD children and adolescents}},
  author    = {Duric, Nezla S. and Elgen, Irene Bircow and Aßmus, Jörg},
  journal   = {Neuropsychiatric Disease and Treatment},
  year      = {2014},
  volume    = {10},
  pages     = {1645},
  doi       = {10.2147/ndt.s66466},
  url       = {https://doi.org/10.2147/ndt.s66466}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201766
201866
201944
202011
202155
202233
202333
202433
202522
202611

Its field-weighted citation impact is 1.86: it has been cited 1.86 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder

  • neurofeedback
  • attention deficit hyperactivity disorder
  • children and adolescents
  • methylphenidate
  • academic performance
  • non-pharmacological treatment
  • treatment comparison

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Duric, N. S., Elgen, I. B., & Aßmus, J. (2014). Self-reported efficacy of neurofeedback treatment in a clinical randomized controlled study of ADHD children and adolescents. Neuropsychiatric Disease and Treatment, 10, 1645. https://doi.org/10.2147/ndt.s66466

How many times has this paper been cited?

38 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Neuropsychiatric Disease and Treatment: sign in and open the PDF from this page.

Who wrote this paper?

Nezla S. Duric, Irene Bircow Elgen, Jörg Aßmus.

What is the DOI of this paper?

10.2147/ndt.s66466, permanently at https://doi.org/10.2147/ndt.s66466. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.